Stoke Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Stoke Therapeutics has a total shareholder equity of $242.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $307.8M and $65.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$281.98m |
| Equity | US$242.71m |
| Total liabilities | US$65.05m |
| Total assets | US$307.76m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0GT's short term assets ($297.0M) exceed its short term liabilities ($44.5M).
Long Term Liabilities: 0GT's short term assets ($297.0M) exceed its long term liabilities ($20.6M).
Debt to Equity History and Analysis
Debt Level: 0GT is debt free.
Reducing Debt: 0GT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0GT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0GT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.